The ontogeny of the human globin genes is an important focus of study both with respect to the fundamental developmental biology and molecular genetics of the control of expression of this complex gene system, but also because modifying this developmental control would be of therapeutic value in the treatment of the prevalent genetic diseases of hemoglobin, such as sickle cell anemia and thalassemia. This has been one of our research emphases for more than 25 years. Among other findings was our demonstration that hydroxyurea, now approved to treat sickle cell anemia by elevating fetal hemoglobin, affects intracellular nitric oxide metabolism, specifically changing cyclic GMP levels. These results brought together our NO (see Annual Reports DK025093 and DK025104) and our sickle cell work and has led us to continue gene expression studies in human hematopoietic cells in collaborative studies. One such study shows that many transcription factors change during ontogeny of human CD34+ erythroid cells in culture, especially related to the JAK-STAT and AKT pathways. In subsequent studies we showed that CD 34+ cells have increased levels of gene expression of the PI3/AKT and MAPK genes related to the mTOR signaling pathways as compared to other hematopoietic cells. We have also used myeloproliferative cells -the main focus of hydroxyurea studies - to show that a variety of angiogenic-related genes are affected by treatment with this agent. More recently these studies have shown that nitric oxide (NO) produced by hydroxyurea, as well as increased synthesis of NO by nitric oxide synthase (NOS) enzymes contribute to the effects of this drug. We have recently reported that high levels of reticulocytosis in early infancy in children with sickle cell anemia is correlated with a subsequent more severe clinical course and have planned studies to see if this relates to adhesive properties of these reticulocytes. We have also helped analyze clinical data from the large number of sickle cell patients followed at NIH and showed that increases of hydroxyurea doses, a surrougate marker for Hb F levels, correlates well with apparent benefit-as measured by organ pathology or mortality-from hydroxyurea therapy. Our long interest in understanding the pain phenotype in these patients has resulted in analyses which suggest that there are both central and peripheral nervous system aspects to perception of pain. We have also shown that elevation of Hb F by hydroxyurea decreases sickle cell pain as measured in these studies with external probes. Importantly our data show that central sensitization to pain is an important component of pain in these patients and is affected by fetal hemoglobin levels. We have recently analyzed data from contrast-enhanced ultrasound perfusion imaging of forearm and myocardial blood flow in sickle cell patients and have found that when corrected for degree of anemia hydroxyurea (hydroxycarbamide) increases blood flow in both or organs and muscle blood flow correlates with fetal hemoglobin levels. Current studies are focused on developing new therapies for sickle cell disease and we have met with representatives of several companies that have potential drugs which alter oxygen affinity and we are having discussions of one or more collaborations with these companies. We have also returned to our previous measurements of NO metabolite levels and of cell-free hemoglobin in these patients, hoping to recruit a larger cohort, to better gauge the potential value of nitrite administration. We continue working with the NIH Office of History in archiving NIH science history, reviewing oral histories, and organizing meetings and lectures, as well as editing symposia on related topics for publication, particularly in the journal Perspectives in Biology and Medicine, and preparing introductory material on these publications. A recent symposium was devoted to the 20th C evolution of genetics into genomics, including developmental biology and immunology, and how the paradigms of these fields have changed with time. We are now organizing several symposia on the recent history of NIH, one of which was presented in conjunction with the NIH Research Festival. We very recently helped develop an exhibit for NIH on the life and work of C.B. Anfinsen, the former head of this Laboratory (Branch), and this will be accompanied by a symposium in the fall of 2018 devoted to his career.

Project Start
Project End
Budget Start
Budget End
Support Year
44
Fiscal Year
2018
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
Zip Code
Darbari, Deepika S; Vaughan, Kathleen J; Roskom, Katherine et al. (2017) Central sensitization associated with low fetal hemoglobin levels in adults with sickle cell anemia. Scand J Pain 17:279-286
Sachdev, Vandana; Sidenko, Stanislav; Wu, Melinda D et al. (2017) Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease. Br J Haematol 179:648-656
Suboti?ki, Tijana; Mitrovi? Ajti?, Olivera; Beleslin-?oki?, Bojana B et al. (2016) Angiogenic factors are increased in circulating granulocytes and CD34(+) cells of myeloproliferative neoplasms. Mol Carcinog :
?oki?, Vladan P; Mojsilovi?, Slavko; Jaukovi?, Aleksandra et al. (2015) Gene expression profile of circulating CD34(+) cells and granulocytes in chronic myeloid leukemia. Blood Cells Mol Dis 55:373-81
Schechter, Alan N (2015) General Introduction. Perspect Biol Med 58:139-40
Fitzhugh, Courtney D; Hsieh, Matthew M; Allen, Darlene et al. (2015) Hydroxyurea-Increased Fetal Hemoglobin Is Associated with Less Organ Damage and Longer Survival in Adults with Sickle Cell Anemia. PLoS One 10:e0141706
?oki?, Vladan P; Mossuz, Pascal; Han, Jing et al. (2015) Microarray and Proteomic Analyses of Myeloproliferative Neoplasms with a Highlight on the mTOR Signaling Pathway. PLoS One 10:e0135463
Schechter, Alan N (2014) Introduction to the symposium on recurrent debates on the causal role of genes. Perspect Biol Med 57:1-3
Meier, Emily Riehm; Byrnes, Colleen; Lee, Y Terry et al. (2013) Increased Reticulocytosis during Infancy Is Associated with Increased Hospitalizations in Sickle Cell Anemia Patients during the First Three Years of Life. PLoS One 8:e70794
Cokic, Vladan P; Smith, Reginald D; Biancotto, Angelique et al. (2013) Globin gene expression in correlation with G protein-related genes during erythroid differentiation. BMC Genomics 14:116

Showing the most recent 10 out of 18 publications